Being developed for oral use, not an injection, the ground-breaking treatment for acute myeloid leukemia will accomplish the work of 3-4 separate drugs, reduce cancer patients’ need for radical procedures and eliminate some unbearable side effects.
• The Hebrew University of Jerusalem researchers are trying to expand the drug’s use to other cancers.
By Ran Reznick, Erez Linn, Maytal Yasur Beit-Or & Israel Hayom Staff
Researchers at the Hebrew University of Jerusalem have recently developed a breakthrough biological drug to treat people suffering from acute myeloid leukemia.
AML is one of the most aggressive cancers, and while other cancers have benefited from new treatments, there has been little encouraging news for most leukemia patients for the past 40 years, the researchers said in a statement. Continue Reading »